Tuesday, March 1, 2022

Terray Therapeutics Names Execs

Pasadena-based Terray Therapeutics, a biotech company focused on using artificial intelligence for small molecule drug discovery, has named two new executives, the company said this morning. The company said said it has appointed Feroze (Fez) Ujjainwalla, PhD, as Head of Business, and Adam D. Hughes, PhD, as Head of Chemistry. Dr. Ujjainwalla wa most recently Director of Business Development and Licensing at Merck, and Dr. Hughes was Executive Director of Medicinal Chemistry at Theravance Biopharma. Terray recently raised $60M in a funding round from Madrona Venture Group, Two Sigma Ventures, Digitalis Ventures, KdT Ventures, Goldcrest Capital, XTX Ventures, Sahsen Ventures, Greentrail Capital and Alexandria Venture Investments.

---